A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic Syndromes (MDS)
Clinical trial NCT06113302 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06113302
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-01
- Primary completion
- 2028-06-02
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.